Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000868278-25-000003
Filing Date
2025-04-01
Accepted
2025-03-31 17:33:13
Documents
101
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K prph-20241231.htm   iXBRL 10-K 1932562
2 EX-23.1 prph-20241231xexx231.htm EX-23.1 2588
3 EX-23.2 prph-20241231xexx232.htm EX-23.2 2311
4 EX-31.1 prph-20241231xexx311.htm EX-31.1 10950
5 EX-32.1 prph-20241231xexx321.htm EX-32.1 5324
11 prph-20241231_g1.gif GRAPHIC 2440
12 screenshot2025-03x31153115.gif GRAPHIC 2440
  Complete submission text file 0000868278-25-000003.txt   11668412

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prph-20241231.xsd EX-101.SCH 81980
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prph-20241231_cal.xml EX-101.CAL 155414
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prph-20241231_def.xml EX-101.DEF 412955
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prph-20241231_lab.xml EX-101.LAB 1072153
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prph-20241231_pre.xml EX-101.PRE 733645
104 EXTRACTED XBRL INSTANCE DOCUMENT prph-20241231_htm.xml XML 1496371
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

EIN.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 25795319
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)